In summary, our present meta-analysis provides evidence of the association between Leptin-2548G/A gene polymorphism and breast cancer risk, and suggests that Leptin-2548G/A gene polymorphism has an increased risk with breast cancer. This evidence concerns the gene LEP and breast carcinoma.